Polyethylenimine-based intravenous delivery of transgenes to mouse lung

D. Goula, C. Benoist, S. Mantero, G. Merlo, G. Levi, B. A. Demeneix

Research output: Contribution to journalArticle

Abstract

Generally, cationic vector-based intravenous delivery of DNA is hindered by interactions of positively charged complexes with serum proteins. However, if optimally formulated, cationic vectors can provide reasonable levels of transfection in the lung either by intravenous or intrapulmonary routes. We investigated the in vivo transfection capacity of a cationic polymer: linear, 22 kDa polyethylenimine. PEI/DNA complexes were formulated in 5% glucose and delivered into adult mice through the tail vein. Two marker genes were used, β-galactosidase and luciferase. High levels of luciferase expression (107 RLU/mg protein) were found in the lung when DNA was complexed with PEI at a ratio of 4 nitrogen equivalents per DNA phosphate. Lower levels of transfection were found in the heart, spleen, liver and kidney. Expression was dose- and time-dependent in all tissues examined. In the lung, β-galactosidase staining showed transgene expression in clusters of 10 or more pulmonary cells including the alveolar endothelium, squamous and great alveolar epithelial cells (type I and II pneumocytes) and septal cells. These findings indicate that the complexes pass the capillary barrier in the lung. Although the delivery mechanism requires elucidation, linear PEI has promise as a vector for intravenous transfer of therapeutic genes.

Original languageEnglish
Pages (from-to)1291-1295
Number of pages5
JournalGene Therapy
Volume5
Issue number9
Publication statusPublished - 1998

Fingerprint

Polyethyleneimine
Alveolar Epithelial Cells
Transgenes
Lung
Galactosidases
Transfection
DNA
Luciferases
Genes
Endothelium
Tail
Blood Proteins
Veins
Polymers
Nitrogen
Spleen
Phosphates
Staining and Labeling
Kidney
Glucose

Keywords

  • Cationic polymers
  • Gene therapy
  • Nonviral
  • Plasmid DNA
  • Pneumocytes

ASJC Scopus subject areas

  • Genetics

Cite this

Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G., & Demeneix, B. A. (1998). Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Therapy, 5(9), 1291-1295.

Polyethylenimine-based intravenous delivery of transgenes to mouse lung. / Goula, D.; Benoist, C.; Mantero, S.; Merlo, G.; Levi, G.; Demeneix, B. A.

In: Gene Therapy, Vol. 5, No. 9, 1998, p. 1291-1295.

Research output: Contribution to journalArticle

Goula, D, Benoist, C, Mantero, S, Merlo, G, Levi, G & Demeneix, BA 1998, 'Polyethylenimine-based intravenous delivery of transgenes to mouse lung', Gene Therapy, vol. 5, no. 9, pp. 1291-1295.
Goula D, Benoist C, Mantero S, Merlo G, Levi G, Demeneix BA. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Therapy. 1998;5(9):1291-1295.
Goula, D. ; Benoist, C. ; Mantero, S. ; Merlo, G. ; Levi, G. ; Demeneix, B. A. / Polyethylenimine-based intravenous delivery of transgenes to mouse lung. In: Gene Therapy. 1998 ; Vol. 5, No. 9. pp. 1291-1295.
@article{b4b0e306d67843eca21b47af48a30108,
title = "Polyethylenimine-based intravenous delivery of transgenes to mouse lung",
abstract = "Generally, cationic vector-based intravenous delivery of DNA is hindered by interactions of positively charged complexes with serum proteins. However, if optimally formulated, cationic vectors can provide reasonable levels of transfection in the lung either by intravenous or intrapulmonary routes. We investigated the in vivo transfection capacity of a cationic polymer: linear, 22 kDa polyethylenimine. PEI/DNA complexes were formulated in 5{\%} glucose and delivered into adult mice through the tail vein. Two marker genes were used, β-galactosidase and luciferase. High levels of luciferase expression (107 RLU/mg protein) were found in the lung when DNA was complexed with PEI at a ratio of 4 nitrogen equivalents per DNA phosphate. Lower levels of transfection were found in the heart, spleen, liver and kidney. Expression was dose- and time-dependent in all tissues examined. In the lung, β-galactosidase staining showed transgene expression in clusters of 10 or more pulmonary cells including the alveolar endothelium, squamous and great alveolar epithelial cells (type I and II pneumocytes) and septal cells. These findings indicate that the complexes pass the capillary barrier in the lung. Although the delivery mechanism requires elucidation, linear PEI has promise as a vector for intravenous transfer of therapeutic genes.",
keywords = "Cationic polymers, Gene therapy, Nonviral, Plasmid DNA, Pneumocytes",
author = "D. Goula and C. Benoist and S. Mantero and G. Merlo and G. Levi and Demeneix, {B. A.}",
year = "1998",
language = "English",
volume = "5",
pages = "1291--1295",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Polyethylenimine-based intravenous delivery of transgenes to mouse lung

AU - Goula, D.

AU - Benoist, C.

AU - Mantero, S.

AU - Merlo, G.

AU - Levi, G.

AU - Demeneix, B. A.

PY - 1998

Y1 - 1998

N2 - Generally, cationic vector-based intravenous delivery of DNA is hindered by interactions of positively charged complexes with serum proteins. However, if optimally formulated, cationic vectors can provide reasonable levels of transfection in the lung either by intravenous or intrapulmonary routes. We investigated the in vivo transfection capacity of a cationic polymer: linear, 22 kDa polyethylenimine. PEI/DNA complexes were formulated in 5% glucose and delivered into adult mice through the tail vein. Two marker genes were used, β-galactosidase and luciferase. High levels of luciferase expression (107 RLU/mg protein) were found in the lung when DNA was complexed with PEI at a ratio of 4 nitrogen equivalents per DNA phosphate. Lower levels of transfection were found in the heart, spleen, liver and kidney. Expression was dose- and time-dependent in all tissues examined. In the lung, β-galactosidase staining showed transgene expression in clusters of 10 or more pulmonary cells including the alveolar endothelium, squamous and great alveolar epithelial cells (type I and II pneumocytes) and septal cells. These findings indicate that the complexes pass the capillary barrier in the lung. Although the delivery mechanism requires elucidation, linear PEI has promise as a vector for intravenous transfer of therapeutic genes.

AB - Generally, cationic vector-based intravenous delivery of DNA is hindered by interactions of positively charged complexes with serum proteins. However, if optimally formulated, cationic vectors can provide reasonable levels of transfection in the lung either by intravenous or intrapulmonary routes. We investigated the in vivo transfection capacity of a cationic polymer: linear, 22 kDa polyethylenimine. PEI/DNA complexes were formulated in 5% glucose and delivered into adult mice through the tail vein. Two marker genes were used, β-galactosidase and luciferase. High levels of luciferase expression (107 RLU/mg protein) were found in the lung when DNA was complexed with PEI at a ratio of 4 nitrogen equivalents per DNA phosphate. Lower levels of transfection were found in the heart, spleen, liver and kidney. Expression was dose- and time-dependent in all tissues examined. In the lung, β-galactosidase staining showed transgene expression in clusters of 10 or more pulmonary cells including the alveolar endothelium, squamous and great alveolar epithelial cells (type I and II pneumocytes) and septal cells. These findings indicate that the complexes pass the capillary barrier in the lung. Although the delivery mechanism requires elucidation, linear PEI has promise as a vector for intravenous transfer of therapeutic genes.

KW - Cationic polymers

KW - Gene therapy

KW - Nonviral

KW - Plasmid DNA

KW - Pneumocytes

UR - http://www.scopus.com/inward/record.url?scp=0031720533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031720533&partnerID=8YFLogxK

M3 - Article

C2 - 9930332

AN - SCOPUS:0031720533

VL - 5

SP - 1291

EP - 1295

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 9

ER -